A list of puns related to "Barda"
In an Actors on Actors discussion with the first filmβs own Michael B. Jordan, she discussed the extent of the filmβs impact on her, which goes way beyond what one would expect. Here you go. Sheβs clearly very passionate about the franchise.
The other day, the very reliable MyTimeToShineHello claimed that Theron and Justin Timberlake had been contacted by Marvel (Timberlake is suspected to be for >!Zeke Stane in Ironheart!<). WF has obviously had its production issues, but we still know the movieβs core cast. Shuri seems to be the lead, and Tenoch Huerta is playing Namor.
However, the movie is missing its typical Hollywood prestige name. Like how Kurt Russell, Michael Douglas and Samuel L. Jackson were credited at the end of the cast billing in their respective movies (besides Captain Marvel and FFH for the latter, which had Jude Law and Jake Gyllenhaal instead), WFβs going to need a prestige name that the βandβ credit can be given to. Andy Serkis took it last time, whilst Boseman and Jordan were the leads. But with all three gone, someone will need to fill that void, and even though Lupita NβYongo, Daniel Kaluuya and Angela Bassett are all Oscar winners, they arenβt stars. Admittedly I wouldnβt call Serkis much of a βstarβ, either, but my other examples still stand.
A while back, an unreliable Twitter account claimed that Lake Bell would be portraying Lucia von Bardas in the upcoming sequel. For those who are unaware, sheβs a Latverian politician who later becomes a cyborg. Whilst I wouldnβt expect Doom to debut this year, much like with Dane Whitman in Eternals, it wouldnβt at all surprise me to see Lucia brought in for some world-building to set up future projects.
My guess is that the account is half-right, and that Theron will portray the character. Sheβs already a seasoned action star, so even though she might not necessarily do her own stunts, this would still be more effective than having CGI completely take over. She was previously considered for Hela in Ragnarok and, infamously, Hippolyta in the Wonder Woman movies.
But hey, itβs just a a theory, a REDDIT THEORY!
β¦Iβm still working on that.
https://twitter.com/barda/status/1471828782818418688
Have not followed up so not sure about this...
I'm not really feeling it with BARDA at this point. I still check every once in a while. The EZ-BAA updated today. This is the smaller of the two programs. I see nothing of note for Athersys in the changes.
https://sam.gov/opp/9777e376e94e4bd6979c3833a74c27db/view
Guys this may be big or it may be a typo/oversight. I need eyes on this ASAP. Does anyone else read the changes for Amendment 29 showing a change in AOI 9.3?
Is it possible (likely) that the ARDS data from the Healios Multistem trial was a trigger to reopen discussion with BARDA? The timing of things seems to fit and our ARDS Japan data was very, very compelling...
That was why they stated about Multistem as a potential COVID-19 ARDS therapeutic in the past. In reality, nothing has changed and the Healios study adds additional confirmation. Certainly getting funding would be a game changer for Athersys and give us the momentum that is sorely needed right now.
So I took everyone's advice the last time I posed and began upgrading Dr. Poison for her AOE. And it was working wonders, until I came across some variation of the team in the title. Aquaman KOA isn't a guaranteed member, and Barda and Azrael seem to swap out for each other, but Terra and Spectre are consistent members. Terra of course protects Spectre from the AoE, and because you've triggered an attack, Azrael either strikes back or Barda buffs and gets her perma-taunt.
It seems like this is impossible quadfecta of DCLegends since it involves protections against debuffs. How have you guys overcome them?
UPDATES: BARDA INDUSTRY DAY - Virtual Event - (Wed. - Thur.) November 3-4, 2021
First Session, for those that registered: https://barda.brandlive.com/barda-bid-2021/en/session/9d004f88-0b55-11ec-9d3a-bf255727e353
Sister Thread: https://www.reddit.com/r/ATHX/comments/qkf8az/barda_industry_day_virtual_event_wed_thur/
Agenda: https://www.medicalcountermeasures.gov/media/38405/bid2021_agenda_final-508-v1.pdf
Day 1 Schedule -
https://preview.redd.it/mkuk49s35ex71.png?width=805&format=png&auto=webp&s=2356d65a64e4d7eb593a495626e747a60df737f7
https://preview.redd.it/08s0wry86ex71.png?width=805&format=png&auto=webp&s=261f26e3680143aa051716baba93868911a73938
https://preview.redd.it/jirzyxei8ex71.png?width=806&format=png&auto=webp&s=889c89917ebcd3364f49b8942c5c609278a787da
***Revised Schedule Day 2 (Note the one hour earlier start time) -
https://preview.redd.it/fkb1z3s1yhx71.png?width=738&format=png&auto=webp&s=b18613f2a2cc2cf9879d883e5819ed145c0c168c
https://preview.redd.it/th2il869yhx71.png?width=738&format=png&auto=webp&s=7d18d1c518655a106b2106d271dd12be83c15965
At Twitter: https://twitter.com/BARDA and #BARDA2021 - https://twitter.com/hashtag/BARDA2021?src=hashtag_click
After the great work of Guru zim and Golgo a few days ago, I thought i'd try my luck and see if I could get a response from Karen regarding possible BARDA funding. Not much information, but this is what I received from her today.
Dear XXXX,
Thank you for your email. Presently, we have not re-engaged in discussions with BARDA but as you point out, the reinstatement of 9.3 does open the door once again for the possibility of working together. While Gary Disbrow, with whom we had several discussions last year, still leads the organization, we will certainly give this possibility consideration.
Thank you for your long time support!
Best Regards,
Karen
Karen Hunady
Director of Corporate Communications & Investor Relations
3201 Carnegie Avenue
Cleveland, OHΒ 44115-2653
--------------------------------------------------------------------------------------------------------------------
My email to Karen
Hello Karen,
I am a long time ATHX shareholder and I have a question:
Amendment 29 dated Oct 26, 2021 to BARDA BAA AOI 9.3 appears to reopen the possibility of ATHX obtaining BARDA funding for treating ARDS. Β Does ATHX plan to pursue BARDA funding in the near future?
Thank you.
XXXXXXX
Hey all,
Watched todayβs BARDA Industry Day sessions and below are a few takeaways and summary of the relevant sessions:
Highlights:
Summary:
BARDA is prioritizing investment and finding solutions for ARDS and late-stage hospital treatments and seemed very open to engaging with partners. And so, with positive One-Bridge Data + Must-ARDS and a P3 trial (Macovia) already organized by FDA and BARDA, Athersys should be at the front of the line for a significant investment.
Below are notes and few screen shots from the relevant sessions:
************
Session I - Keynote β Gary Disbrow, Director BARDA
Gary discussed the following -
Β· FY21 Covid Achievements and FY22 Funding Levels ($2.1B)
Β· How BARDA is moving to preparedness for next pandemic (pathogen independent)
Β· Discussed FY22 Initiatives on the below slide.
Β· Gary said these are seeking to invest in therapeutics for hospitalized patients including Acute Lung Injury (ALI) and ARDS
Β· He said the program directors would discuss each strategic initiative during the sessions.
Edit: Forgot to include this slide "BARDA's Role in Future Pandemic Responses" which Gary outlined during the keynote prior to the reviewing the FY22 initiatives.
https://preview.redd.it/hxkb1f041lx71.png?width=943&format=png&aut
... keep reading on reddit β‘Hi all.
I've gotten through the text of the BAA and there is a lot to go through this time. This was not a small change, this was not just one or two items being updated. This was the big, wholesale update to the BAA that I've been looking for, and spoiler alert, 9.3 is not the only interesting change.
All of the documents can be found here (Change summaries, special instructions, and the BAA in most of its forms - everything recent is here) SAM.gov
I'm going to ignore 9.3 for now, because we've already talked about it and Golgo with through it point by point in the earlier thread. Read this if you have not, it's good stuff.
This is going to be a long one. Throughout this post, any bold is my addition.
Here are the changes from the change document, just relevant to Amendment 29.
>β’ Revised 1.2 Ebola and Marburg virus
>
>β’ Deleted 1.3 Antimicrobial Resistant Threats
>
>2. Updates to Area of Interest #2: CBRN Antivirals and Antitoxins
>
>β’ Revised 2.1 Anthrax Antitoxins
>
>β’ Revised 2.2 Botulism Antitoxins
>
>β’ Revised 2.3 Smallpox Antiviral
>
>β’ Deleted 2.4 Viral Hemorrhagic Fevers Antiviral
>
>β’ Added New 2.4 Filovirus Therapeutics
>
>3. Updates to Area of Interest #3: Antibacterials
>
>β’ Deleted 3.1 Develop antibacterial products for post exposure prophylaxis (PEP) and treatment of one or more biothreat pathogens
>
>β’ Deleted 3.2 Develop new drugs that treat or prevent resistant bacterial infections either alone or in combination with other therapeutics
>
>β’ Deleted 3.3 Develop non-traditional therapeutics that treat or prevent resistant infections β’ Added
>
>New 3.1 Develop products for treatment of MDROs and biothreat pathogens
>
>4. Updates to Area of Interest #4: Radiological/Nuclear Threat Medical Countermeasures
>
>β’ Revised 4.1 Advanced Development of MCMs to treat radiation injury due to acute exposure to ionizing radiation
>
>β’ Revised 4.2 Blood Products
>
>5. Updates to Area of Interest #5: Chemical Threat Medical Countermeasures
>
>β’ Revised 5.1 Pulmonary Agents
>
>β’ Revised 5.2 Opioids
>
>β’ Revised 5.3 Vesicants
>
>β’ Revised 5.4 Blood/Metabolic Agents
>
>β’ **Revised
These severe cases need MS and they need it now.
https://www.frontiersin.org/articles/10.3389/fmed.2021.778434/full
Athersys should be knocking on doors
He is not a good counter for Barda. While Arkis is a great toon and he can kill Barda with his second, that it's only possible if she doesn't have a lot of her buffs.
The fact is, Barda is a physical tank, and she defends very well against physical attacks like Arkis.
The best counter to Barda in the game that you can farm for free is SSS Lex. Not only he can put buff immunity on her but also he does Special damage. You can also use Zod, Eradicator, Grodd, Larfleeze. And these are only a few greens that deal special damage as well. You can check all characters in the https://dcltoolkit.com/characters/, to see if they do physical damage like Arkis or special damage like the others I mentioned.
Keep in mind that Physical damage increases with Strength ups while Special damage increases with intelligence ups. On the same way the contrary, if you Arkis or an Azrael that has a lot of strength downs they will do a lot less damage.
I am not saying that you can't use characters that use physical damage to hit characters that defend with the same, it's only that the damage is a lot less.
One character that is very useful against Barda is Black Manta, where he can't turn up to 5 of her mends into bleeds. The few reasons I don't recommend him as the best counters are one, he is not farmable, two, it's not guaranteed five bleeds, and three, he dies way too easily in my opinion.
BARDA INDUSTRY DAY - Virtual Event - (Wed. - Thur.) November 3-4, 2021
Strengthening Partnerships, Advancing Innovation
Registration Now Open! Check out our confirmed speakers, high-level schedule, sign-up for emails and other information. (Simple and Free Registration!...I answered honestly...Took me about 5 minutes to register...) Link - https://www.medicalcountermeasures.gov/barda/barda-industry-day-2021/
(Copy & Paste) WHAT IS BARDA INDUSTRY DAY?
BARDA Industry Day is our annual conference, held to increase awareness of U.S. government medical countermeasure priorities, interact with BARDA and ASPR staff, and network with public and private sector colleagues working in the health security space. During BARDA Industry Day 2020, the one-day virtual event attracted 1300+ attendees, featured BARDA program goals and funding updates, expert presentations from government and industry partners, 13 interactive breakout sessions, and two Lightning Talk sessions showcasing 20 exciting technologies.
This year, BARDA Industry Day 2021 will be a two-day virtual event featuring keynote addresses by industry and government partners, including opening remarks from the BARDA director, BARDA divisional updates on programmatic goals, special topic breakout sessions, as well as a variety of networking opportunities with BARDA experts and other guests.
BARDA Industry Day has grown into a premiere annual health security event. This yearβs virtual conference will be an exciting opportunity to explore how the field of medical countermeasures is constantly on the cutting edge of innovation, and how we can work together to prepare for 21st century health security threats. We look forward to seeing you at BARDA Industry Day 2021!
On the AGENDA (There may be other topics of interest)...At first glance, this one caught my eye...
"Therapeutic Development for ARDS Breakout"
Day 2 - Thur. Nov. 4, 2021 -
https://preview.redd.it/y50riyznszw71.png?width=1088&format=png&auto=webp&s=f3d372a38f7af8773e41bed623fc4f079880ac2e
https://preview.redd.it/6mov8sm1tzw71.png?width=582&format=png&auto=webp&s=cd335bcb316e9822611bd4e287f8e5bf21f8dfaa
Tweet Link - https://twitter.com/BARDA/status/1452781774061322240?s=20
**Simple & Free Registration!...I answered honestly...Took me about 5
... keep reading on reddit β‘Hola. la situaciΓ³n es esta. Mi vecino de al lado no tiene contra barda, y de mi barda ya colgΓ³ macetas, lonas, clavo unas estacas. Hable con el civilizadamente hace como un aΓ±o pidiendole que quitara todo de mi pared/barda. Es lo hora que no lo ha hecho, y no me quiero desgastar en exigirle que lo haga. Se puede demandar legalmente por este hecho? No queria llegar a este extremo. Gracias de antemano
edit: there was another tweet which stated that doom will not be in the movie, but this does serve as a gateway for him to appear in future projects
Hey all,
Below are today's slides from the ARDS Therapeutic breakout session. The prezo built on yesterdays theme of "pathogen independence" and how ARDS is derived from multiple sources - Sepsis, Chemical, Flu and Antibacterial. After a short introduction, four presenters outlined their specific challenges followed by Q&A.
Key Takeaways: When you look at the entire movie over two days, BARDA clearly recognizes the absence of available ARDS treatments translates to long hospitalizations, poor patient outcomes, increased mortality, high hospital costs etc... Good news is BARDA is eager to fund relevant treatments which should be great news for Athersys, the worlds ARDS leader!
https://preview.redd.it/x3shcg9yxnx71.png?width=960&format=png&auto=webp&s=4d4ba4211b5c322c030eee6c856c9fed3d0e50e2
https://preview.redd.it/gxbjsf52tnx71.png?width=818&format=png&auto=webp&s=efae0af61fd0e16799e3f7b1f5c738df08b1a167
https://preview.redd.it/v5sux6f5tnx71.png?width=747&format=png&auto=webp&s=72a2e5332212ef12b4086a0246e5ba3087bfa8fc
https://preview.redd.it/ncoz96s9tnx71.png?width=727&format=png&auto=webp&s=806c89ffd0f9ce5f5725fba21148c144e6ac0f93
https://preview.redd.it/uxpiiaectnx71.png?width=690&format=png&auto=webp&s=53b2d4a58cfad238f6d7077a5fbdecfcdcfa4715
https://preview.redd.it/b7eta7vetnx71.png?width=725&format=png&auto=webp&s=858b573c1b19d96463c1c9dc77b8e27d1b46bc3e
https://preview.redd.it/ydtmg63itnx71.png?width=640&format=png&auto=webp&s=811ba45527bf038ca8b34d5daa1e5137c7a61871
https://preview.redd.it/ugen6f6ltnx71.png?width=695&format=png&auto=webp&s=44da3a8bc5bd5e25d9fa282dd08a6a070b60cc39
https://preview.redd.it/1ulea1gntnx71.png?width=610&format=png&auto=webp&s=d3a995212508e7182ed8fc39a2e1935cf81f6281
https://preview.redd.it/24m9pw8qtnx71.png?width=610&format=png&auto=webp&s=2f12704c3ed01d725663348480cac684ff14b0e5
https://preview.redd.it/f5vmdbrstnx71.png?width=610&format=png&auto=webp&s=c5a6de28b80075c010cab643005e4d3c01d8164c
https://preview.redd.it/sa2jci6vtnx71.png?width=610&format=png&auto=webp&s=5e34a213baed53b89f90f40e3c30c0071aeeaeaa
https://preview.redd.it/nli3aiqxtnx71.png?width=722&format=png&auto=webp&s=1e96b4378f1c54be615d3a5b3b5b6408a6cb19aa
https://preview.redd.it/0x7jj5pztnx71.png?width=610&format=png&auto=webp&s=1a2aea2ee78f5aae919d
... keep reading on reddit β‘Please note that this site uses cookies to personalise content and adverts, to provide social media features, and to analyse web traffic. Click here for more information.